(Phyllanthaceae)

An insight into the potent medicinal plant Phyllanthus amarus Schum. and Thonn

Phyllanthus amarus Schum. and Thonn., a globally distributed herb is known for its several therapeutic potentials. P. amarus has a long history of use in the traditional system of medicine for over 2000 years owing to its wide array of secondary metabolites that confer significant medicinal attributes. Research on various aspects including ethnobotany, phytochemistry to bioactivity, or pharmacological studies has been conducted over the past several decades on this potent herb. P. amarus extracts have shown a broad range of pharmacological activities like hepatoprotective, antioxidant, antiviral, antimicrobial, antidiabetic, anti-inflammatory, anticancer, antimalarial, nephroprotective, diuretic, and several other properties. The present review compiles and covers literature and research of several groups across past decades to date and focuses on how the therapeutic significance of this plant can be further explored for future research either as herbal formulations, alternative medicine, or in the pharmaceutical industry.

Supplementary Information

The online version contains supplementary material available at 10.1007/s13237-022-00409-z.

Antioxidant and antidiabetic activities of vanadium-binding protein and trifuhalol A

The antioxidant and antidiabetic activities of vanadium-binding protein (VBP) and trifuhalol A, alone or combined, were investigated. Both VBP and trifuhalol A showed potent radical scavenging activity (RSA) on 2,2'-azinobis (3-ethylbenzothiazoline)-6-sulfonic acid (ABTS), hydrogen peroxide, and ferric-reducing antioxidant power. Their combination at a concentration of 100 μg/ml VBP and 40 μg/ml trifuhalol A exhibited more than 99% RSA against ABTS. Additionally, VBP and trifuhalol A, alone or combined, displayed potential antidiabetic activities against Saccharomyces cerevisiae α-glucosidase. The highest inhibition of 70.26% against S. cerevisiae α-glucosidase was observed in the case of the combination of 250 μg/ml VBP and 1.75 μg/ml trifuhalol A. Kinetics study revealed that VBP and trifuhalol A were noncompetitive inhibition type against S. cerevisiae α-glucosidase, while VBP and trifuhalol A combined treatment was a mixed inhibition type against S. cerevisiae α-glucosidase. These results indicated that VBP and trifuhalol A, alone or combined, had high free radical scavenging activity and inhibitory activity against S. cerevisiae a-glucosidase, suggesting that VBP and trifuhalol A could be used as candidates for the development of natural antidiabetic drugs or functional food. PRACTICAL APPLICATIONS: The present study showed that VBP and trifuhalol A, alone or combined, had potential antioxidant and antidiabetic activities, suggesting that VBP and trifuhalol A could be developed to a novel nutraceutical or natural antidiabetic drugs in the management of obesity or diabetes. This finding will be beneficial for all peoples who are directly or indirectly associated with obesity or diabetes.

In vitrogastrointestinal digestibility of phytosterol oleogels: influence of self-assembled microstructures on emulsification efficiency and lipase activity

The objective of this study was to investigate the influence of a self-assembled microstructure on lipid digestibility of phytosterol (γ-oryzanol and β-sitosterol) oleogels, including the oil emulsification process and further lipolysis.

Ethnopharmacological analysis of medicinal plants used against non-communicable diseases in Rodrigues Island, Indian Ocean

ETHNOPHARMACOLOGICAL RELEVANCE

Rodrigues is an autonomous outer island that form part of the Republic of Mauritius and one of three islands that constitute the Mascarene archipelago in the Indian Ocean. Though herbal medicine is in common use in Rodrigues, there has been no ethnopharmacological study to document quantitatively such traditional practise particularly against non-communicable diseases (NCD) which is currently a growing major health issue on the island. The aim of the present study was to collect, analyse and document traditionally used medicinal plants (MP) from key informants and traditional medicine practitioners (TMP) in the tropical island of Rodrigues to treat and/or manage common NCD.

MATERIALS AND METHODS

Data was collected via face-to-face interviews with MP users (n=113) and TMP (n=9). Seven quantitative ethnopharmacological indices, namely family use value (FUV), use value (UV), informant agreement ratio (IAR), relative frequency of citation (RFC), fidelity level (FL), relative importance (RI) and ethnobotanicity index (EI) were calculated.

RESULTS

Hundred and three plants belonging to 55 families were recorded for the treatment and/or management of 27 different NCD. Three of the MP (Terminalia bentzoë (L.) L.F, Sarcostemma cf. adontolepis Balf.f. and Clerodendrum laciniatum Balf.f.) recorded are endemic to Rodrigues and 2 (Carissa xylopicron Thouars., Phyllanthus casticum Willemet f.) endemic to the Mascarene Islands. The most solicited MP family was Asteraceae with a total of 8 species. Citrus aurantifolia (Christm.) Swingle scored the highest RFC (RFC=1.02) value. Ten plants were found to score 100% FL and the highest IAR (0.98) was observed for the disease category of certain conditions originating in the perinatal period. Arecaceae scored the highest FUV value and Ayapana triplinervis (Vahl) R.M. King et H.Rob highest UV (UV= 2.72).

CONCLUSION

Given the dearth of updated information on traditional medicine of Rodrigues, this study can provide an opportunity to establish valuable primary information on the different MP used by the local people and hence can open new perspectives for further pharmacological research.